PharmaRoth Labs, Inc. (ROTH)

[old biohf guy]

A lot of half-truths as usual.

First, the FDA did not ban Sucanon. They just did not approve an application for over-the-counter sales.

Second, Sucanon was not denied by the FDA. They just did not approve an application for over-the-couunter sales.

Third, actually, the application for over-the-counter sales was not approved only because the FDA determined that Sucanon is a drug. This is good news and bad news. Good in that it is classified as a drug, but bad because sales of Sucanon could not be sold immediately over-the-counter.

Fourth, of course no sales in Canada is not a good thing, but this is only becaue a distributor has not been set up yet in Canada.

Fifth, you say that "stock is a loser". This is a relative and meaningless term. Every stockholder surely wants the price to be higher and when India aproves Sucanon the price will surely go up. When Canagen starts to sell in India surely the price will go up. When the clinial trial results from ABC Hospital in Mexico are released surely the price will go up. The investors do not own Roth for its present sales and financial condition, but rather for the huge future potential.

Sixth, the revoked business license in Nevada is bogus as this has been reassigned to Wyoming as I understand it. Please do some unbiased research here if you can.